| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Purchase | $6,080,824 | +42,076 | +0.76% | $144.52 | 5,555,715 | 01 Sep 2022 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Purchase | $7,062,556 | +48,714 | +0.88% | $144.98 | 5,604,429 | 02 Sep 2022 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2022, and amended on May 3, 2022. |
| F2 | The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $143.20 to $145.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $144.70 to $145.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |